Immunology and Microbiology
Vaccination Policy
100%
T Cell
98%
Memory T Cell
81%
Immunocompetent Cell
67%
COVID-19
66%
Severe Acute Respiratory Syndrome Coronavirus 2
66%
Influenza
44%
Cytomegalovirus
44%
Immunosenescence
38%
T Cell Receptor
33%
Adoptive Immunity
33%
Dynamics
33%
Immunity
33%
Immune Landscape
33%
Vaccine Efficacy
27%
CD4
23%
Immune Disorder
22%
Immune System
16%
Age
16%
Immunological Method
16%
Life Expectancy
16%
CD38
14%
Follicular B Helper T Cells
11%
Seropositivity
11%
Immune System
11%
HLA-DR
8%
Antibody Response
8%
T-Helper Cell
8%
Antibody Blood Level
7%
Cell Expansion
7%
CD8
6%
Cell Composition
6%
Antibody Titer
5%
Monocyte
5%
Immune Response
5%
Hemagglutination Inhibiting Antibody
5%
Face
5%
Antigen Specificity
5%
ELISPOT
5%
Virus Nucleocapsid
5%
Spike
5%
Immunological Memory
5%
Medicine and Dentistry
Memory T Cell
83%
Severe Acute Respiratory Syndrome Coronavirus 2
83%
COVID-19
66%
Immunocompetent Cell
55%
Influenza Vaccination
50%
T-Cell Response
47%
Immunosenescence
44%
Symptom
38%
Cellular Immunity
33%
Immune System
33%
Messenger RNA
33%
Humoral Immunity
33%
Immunity
33%
Biological Marker
33%
Infection
27%
T Cell
27%
Infectious Disease
22%
Antibody Response
19%
Monocyte
16%
Immune Response
16%
Hemagglutination Inhibiting Antibody
16%
Health Outcomes
16%
Booster Dose
16%
Hemagglutination Inhibition
16%
High Risk Population
16%
Middle Age
16%
Clinical Trial
16%
Influenza A Virus (H3N2)
16%
Life Expectancy
11%
Deterioration
11%
Immune System
11%
Age
11%
Diseases
11%
Immunological Method
11%
T-Helper Cell
8%
Immunological Memory
5%
Nucleocapsid Protein
5%
Antigen Specificity
5%
Enzyme Linked Immunospot Assay
5%
Reinfection
5%
Keyphrases
T Cells
42%
Aging
33%
T Cell Response
33%
T-cell Phenotype
33%
Vaccine Response
33%
Mild COVID-19
33%
Cytomegalovirus
33%
Epstein-Barr Virus
33%
Immune Stability
33%
Middle-aged Adults
33%
COVID-19 Dynamics
33%
T-cell Receptor Sequencing
33%
Lessons Learned
33%
Phase IV Trial
33%
Immune Subsets
25%
Pneumococcal Conjugate Vaccine
22%
Cell Pools
22%
Specific T Cells
22%
Vaccination
22%
T Cell Expansion
22%
CD4+
20%
Cell number
20%
Senior Adults
12%
Vaccine-induced Immunity
11%
Multiple Samples
11%
Specific Memory
11%
Memory T Cells
11%
Cause-specific
11%
Vaccine Evaluation
11%
Major Histocompatibility Complex
11%
T-cell Receptor Repertoire
11%
Quantitative Requirement
11%
T Cell Receptor
11%
Pneumococcal Vaccine
11%
Small Fragments
11%
Proof of Concept Study
11%
Targeted Vaccines
11%
Personalized Vaccination
6%
PCV13 Vaccine
6%
Immune Parameters
6%
Effector Memory
6%
Immune Cells
6%
Effector Memory T Cells
6%
CD8+
6%
